Quantitative Profiling Method for Oxylipins in Neurodegenerative Diseases by Liquid Chromatography Coupled with Tandem Mass Spectrometry
Preprint
Abstract
Aging is one of the major risk factors for many chronic diseases, including diabetes, neuropathy, hypertension, cancer, and neurodegenerative diseases. However, the mechanism behind aging and how aging affects a variety of disease progression remains unknown. Recent research demonstrated the cytochrome P450 (CYP)-epoxide hydrolase (EH) metabolites of polyunsaturated fatty acids (PUFAs) play a critical role in the abovementioned age-associated diseases. Therefore, aging could affect the abovementioned chronic diseases by modulating CYP-EH PUFA metabolism. Unfortunately, investigating how aging affects CYP-EH metabolism in human and mammalian models poses significant challenges. In this regard, we will use C. elegans as a model organism to investigate the aging effects on CYP-EH metabolism of PUFA, owing to its long history of being used to study aging and its associated benefits of conducting aging research. This project will develop analytical tools to measure the endogenous levels of CYP-EH PUFA metabolites in C. elegans using state-of-the-art ultra-performance liquid chromatography coupled with tandem mass spectrometry (UPLC-MS/MS). These metabolites are very potent but present in low abundance. The dramatic increase in sensitivity in UPLC-MS/MS allows us to monitor these metabolites over the lifespan of C. elegans with minimum samples. Our results show that C. elegans produces similar CYP PUFA metabolites to mammals and humans using our SPE-UPLC-MS/MS method. We will also show that our method successfully determined the CYP-EH PUFA metabolites profile changes induced by the inhibition of C. elegans EH. The method developed from this project will significantly improve our understanding of the role of dietary PUFAs and associated metabolism on aging and neurodegeneration and will uncover new mechanisms of how aging affects neurodegeneration through the modulation of PUFA metabolic pathways. GraphicalKeywords
This publication has 48 references indexed in Scilit:
- Plasma and serum oxylipin, endocannabinoid, bile acid, steroid, fatty acid and nonsteroidal anti-inflammatory drug quantification in a 96-well plate formatAnalytica Chimica Acta, 2021
- Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's DiseaseNeurotherapeutics, 2020
- 2019 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2019
- Non-human primates as a model for agingBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2018
- Polyunsaturated fatty acid derived signaling in reproduction and development: Insights from Caenorhabditis elegans and Drosophila melanogasterMolecular Reproduction and Development, 2013
- The use of FUdR can cause prolonged longevity in mutant nematodesMechanisms of Ageing and Development, 2010
- Identification of two epoxide hydrolases in Caenorhabditis elegans that metabolize mammalian lipid signaling moleculesArchives of Biochemistry and Biophysics, 2008
- Life span of the wild and mutant nematode Caenorhabditis elegansExperimental Gerontology, 1982
- A simple method for maintaining large, aging populations of Caenorhabditis elegansMechanisms of Ageing and Development, 1980
- Sterilization and growth inhibition of Caenorhabditis elegans by 5-fluorodeoxyuridineExperimental Gerontology, 1978